chlorpromazine has been researched along with fasudil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Burban, A; Burbank, M; Guguen-Guillouzo, C; Guillouzo, A; Le Guevel, R; Li, R; Sharanek, A | 1 |
3 other study(ies) available for chlorpromazine and fasudil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bile Acids and Salts; Bile Canaliculi; Cardiac Myosins; Cell Survival; Cells, Cultured; Chlorpromazine; Cyclosporine; Hepatocytes; Humans; Microscopy, Fluorescence; Myosin Light Chains; Myosin Type II; Myosin-Light-Chain Kinase; Phosphorylation; rho-Associated Kinases; Signal Transduction; Time-Lapse Imaging; Zonula Occludens-1 Protein | 2016 |